Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.16 USD | +9.85% | +22.33% | -46.43% |
15/05 | Cabaletta Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
22/03 | HC Wainwright Adjusts Cabaletta Bio's Price Target to $30 From $25, Maintains Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-46.43% | 53Cr | |
+16.93% | 12TCr | |
+17.01% | 11TCr | |
-7.23% | 2.38TCr | |
+1.98% | 2.24TCr | |
-14.29% | 1.75TCr | |
-6.79% | 1.66TCr | |
-37.63% | 1.64TCr | |
+2.17% | 1.34TCr | |
+24.42% | 1.15TCr |
- Stock Market
- Equities
- CABA Stock
- News Cabaletta Bio, Inc.
- Transcript : Cabaletta Bio, Inc. Presents at Morgan Stanley 18th Annual Global Healthcare Conference, Sep-14-2020 03